CVS HEALTH CORPORATION (CVS) /

The cash flow of CVS HEALTH CORPORATION over the past 10 years

Chart CVS HEALTH CORPORATION: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, CVS HEALTH CORPORATION's operating cash flow was $10.64B and its capital expenditures $2.83B, leaving free cash flow of $7.81B. Free cash flow was above zero in all 10 years shown. It ranged from $6.09B in fiscal 2017 to $15.74B in fiscal 2021. Capital expenditures were highest in fiscal 2023, at $3.03B.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$10.64B$2.83B$7.81B
2024ended Dec 31, 2024$9.11B$2.78B$6.33B
2023ended Dec 31, 2023$13.43B$3.03B$10.39B
2022ended Dec 31, 2022$16.18B$2.73B$13.45B
2021ended Dec 31, 2021$18.27B$2.52B$15.74B
2020ended Dec 31, 2020$15.87B$2.44B$13.43B
2019ended Dec 31, 2019$12.85B$2.46B$10.39B
2018ended Dec 31, 2018$8.87B$2.04B$6.83B
2017ended Dec 31, 2017$8.01B$1.92B$6.09B
2016ended Dec 31, 2016$10.14B$2.22B$7.92B

Fiscal years as CVS HEALTH CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on CVS HEALTH CORPORATION

Companies of a similar size

Not investment advice. This page shows what CVS HEALTH CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.